To examine the safety and tolerability of lenalidomide in combination with 5-azacitidine as maintenance therapy for Acute Myeloid Leukaemia (AML) in complete remission after intensive chemotherapy.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2011
This article has no abstract
Epistemonikos ID: f749093e5064bc3deaaf65e9ef236a16e6b8b368
First added on: Feb 22, 2025